-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
BioCrude Technologies USA, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q1 2023 to Q1 2024.
- BioCrude Technologies USA, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2024 was $0.000.
- BioCrude Technologies USA, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$2.24K, a 103% decline from 2022.
- BioCrude Technologies USA, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$1.1K, a 78.3% increase from 2021.
- BioCrude Technologies USA, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$5.09K.